| Variable | Frequency n = 10887 (100%) | Undetectable N = 2708 (24.9%) | <40 cp/mL 3197 (29.4%) | 41 - 500 cp/mL 1922 (17.6%) | 501 - 1000 cp/mL 363 (3.3%) | >1000 cp/mL 2697 (24.8%) | p-value |
| Ages |
| ||||||
| 0 - 9 yrs | 311 (2.9) | 54 (17.4) | 54 (17.4) | 38 (12.2) | 8 (2.6) | 157 (50.5) | <0.001 |
| 11 - 18 yrs | 386 (3.5) | 73 (18.9) | 54 (14.0) | 42 (10.9) | 16 (4.1) | 201 (52.1) |
|
| 19 - 25 yrs | 797 (7.3) | 198 (24.8) | 181 (22.7) | 168 (21.1) | 23 (2.9) | 227 (28.5) |
|
| 26 - 45 yrs | 7098 (65.2) | 1810 (25.5) | 2114 (29.8) | 1256 (17.7) | 248 (3.5) | 1670 (23.5) |
|
| 46 - 55 yrs | 1583 (14.5) | 400 (25.3) | 550 (34.7) | 274 (17.3) | 44 (2.8) | 315 (19.9) |
|
| 56 - 65 yrs | 562 (5.2) | 137 (24.4) | 188 (33.5) | 117 (20.8) | 20 (3.5) | 100 (17.8) |
|
| >65 yrs | 150 (1.3) | 36 (24.0) | 56 (37.3) | 27 (18.0) | 4 (2.7) | 27 (18.0) |
|
| Sex |
| ||||||
| Males | 3094 (28.4) | 702 (22.7) | 912 (29.5) | 560 (18.1) | 99 (3.2) | 821 (26.5) | 0.007 |
| Females | 7793 (71.6) | 2006 (25.7) | 2285 (29.3) | 1362 (17.5) | 264 (3.4) | 1876 (24.1) |
|
| ART Regimen |
| ||||||
| AZT + 3TC + NVP | 5855 (53.8) | 1473 (25.2) | 1677 (28.6) | 929 (15.9) | 205 (3.5) | 1571 (26.8) | <0.001 |
| TDF + 3TC + EFV | 4864 (44.7) | 1196 (24.6) | 1479 (30.4) | 956 (19.7) | 152 (3.1) | 1081 (22.2) |
|
| TDF + FTC + EFV | 114 (1.0) | 28 (24.6) | 24 (21.1) | 29 (25.4) | 3 (2.6) | 30 (26.3) |
|
| AZT + 3TC + LPV/r | 54 (0.5) | 11 (20.4) | 17 (31.5) | 8 (14.8) | 3 (5.6) | 15 (27.8) |
|
| ART Type |
| ||||||
| 1st line | 10568 (97.1) | 2667 (25.2) | 3113 (29.4) | 1848 (17.5) | 348 (3.3) | 2592 (24.5) | 0.942 |
| 2nd line | 282 (2.6) | 28 (9.9) | 82 (29.0) | 67 (23.8) | 14 (5.0) | 91 (32.3) |
|
| 3rd line | 37 (0.3) | 13 (35.1) | 2 (5.4) | 7 (19.0) | 1 (2.7) | 14 (37.8) |
|
| Duration on ART |
| ||||||
| 1 yr | 811 (7.4) | 180 (22.2) | 221 (27.3) | 146 (18.0) | 35 (4.3) | 229 (28.2) | <0.001 |
| 1 - 5 yrs | 5275 (48.5) | 1345 (25.5) | 1484 (28.1) | 1023 (19.4) | 180 (3.4) | 1243 (23.6) |
|
| 6 - 10 yrs | 4075 (37.4) | 1042 (25.6) | 1185 (29.1) | 644 (15.8) | 132 (3.2) | 1072 (26.3) |
|
| >10 yrs | 726 (6.7) | 141 (19.4) | 307 (42.3) | 109 (15.0) | 16 (2.2) | 153 (21.1) |
|
| CD4 count |
| ||||||
| <350 | 3371 (31.0) | 633 (18.8) | 812 (24.1) | 605 (17.9) | 94 (2.8) | 1227 (36.4) | <0.001 |
| 350 - 499 | 2466 (22.7) | 631 (25.6) | 765 (31.0) | 473 (19.2) | 82 (3.3) | 515 (20.9) |
|
| 500 - 999 | 4240 (39.0) | 1197 (28.2) | 1366 (32.2) | 722 (17.0) | 158 (3.7) | 797 (18.8) |
|
| 1000 - 1500 | 662 (6.0) | 208 (31.4) | 213 (32.2) | 106 (16.9) | 21 (3.2) | 114 (17.2) |
|
| >1500 | 148 (1.3) | 39 (26.4) | 41 (27.7) | 16 (10.8) | 8 (5.4) | 44 (29.7) |
|
| Reason for request of viral load |
| ||||||
| Routine | 10479 (96.3) | 2604 (24.8) | 3091 (29.5) | 1847 (17.6) | 351 (3.3) | 2586 (24.7) |
|
| Suspected clinical failure | 258 (2.4) | 71 (27.5) | 76 (29.5) | 53 (20.5) | 8 (3.1) | 50 (19.4) | <0.001 |
| Suspected immunological failure | 150 (1.4) | 33 (22.0) | 30 (20.0) | 22 (14.6) | 4 (2.7) | 61 (40.7) |
|
| ART START YEAR |
| ||||||
| 2000-2004 | 92 (0.8) | 23 (25.0) | 38 (41.3) | 18 (19.6) | 1 (1.1) | 12 (13.0) | 0.076 |
| 2005-2009 | 2945 (27.1) | 750 (25.5) | 945 (32.1) | 433 (14.7) | 82 (2.8) | 735 (24.9) |
|
| 2010-2014 | 5172 (47.5) | 1309 (25.3) | 1454 (28.1) | 941 (18.2) | 185 (3.6) | 1283 (24.8) |
|
| 2015-2018 | 2678 (24.6) | 626 (23.4) | 760 (28.4) | 530 (19.7) | 95 (3.5) | 667 (24.9) |
|